[Skip to Content]
[Skip to Content Landing]
May 1969

Corticosteroid Treatment in BronchiolitisA Controlled, Collaborative Study in 297 Infants and Children

Author Affiliations

Bloomfield, NJ; Boston; Torrance, Calif; Chicago; Columbus, Ohio; New York
From the Department of Clinical Investigation, Schering Corporation, Bloomfield, NJ (Dr. Leer); the Department of Pediatrics, Children's Hospital Medical Center (Dr. Green); the Department of Pediatrics, University of California at Los Angeles School of Medicine and the Department of Pediatric Allergy and Immunology, Harbor General Hospital, Torrance, Calif (Dr. Heimlich); the Department of Pediatrics, University of Illinois College of Medicine, and the Presbyterian-St. Luke's Hospital, Chicago (Dr. Hyde); the Department of Pediatrics, Northwestern University School of Medicine, Chicago (Dr. Moffet); the Department of Pediatrics, Ohio State University College of Medicine, Columbus, Ohio (Dr. Young); and the Department of Biometry, Rockefeller University, New York (Dr. Barron). Dr. Green is now with the Department of Pediatrics, University of Rochester School of Medicine, Rochester, NY.

Am J Dis Child. 1969;117(5):495-503. doi:10.1001/archpedi.1969.02100030497001

A DOUBLE-BLIND study on the effect of betamethasone sodium phosphate in the treatment of 297 infants and children with acute bronchiolitis was conducted at five hospitals from December 1963 to June 1965. For this study, the investigators designed a common protocol and standard case report forms for use at the five collaborating centers. The information obtained permitted an evaluation of the effects of the corticosteroid in bronchiolitis and provided further insight into the natural history of the disease. The study was not designed to explore the causes of bronchiolitis or the effect of supportive treatment.

In recent years, corticosteroids have been used in the treatment of bronchiolitis on the hypothesis that their anti-inflammatory action would reduce bronchiolar inflammation and swelling. These drugs have been regarded as ineffective by some investigators and lifesaving by others. In 1964, Sussman et al1 reported no change in the clinical course of 49 bronchiolitic

First Page Preview View Large
First page PDF preview
First page PDF preview